1. Home
  2. ALNT vs ZYME Comparison

ALNT vs ZYME Comparison

Compare ALNT & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allient Inc.

ALNT

Allient Inc.

HOLD

Current Price

$88.82

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$24.86

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALNT
ZYME
Founded
1962
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
ALNT
ZYME
Price
$88.82
$24.86
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
$64.50
$38.90
AVG Volume (30 Days)
292.3K
596.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
0.16%
N/A
EPS Growth
67.09
33.33
EPS
0.32
N/A
Revenue
$554,478,000.00
$105,965,000.00
Revenue This Year
$7.53
$183.10
Revenue Next Year
$6.64
N/A
P/E Ratio
$277.50
N/A
Revenue Growth
4.62
38.87
52 Week Low
$36.85
$11.86
52 Week High
$104.65
$29.75

Technical Indicators

Market Signals
Indicator
ALNT
ZYME
Relative Strength Index (RSI) 49.59 48.59
Support Level $81.21 $24.79
Resistance Level $104.65 $27.15
Average True Range (ATR) 5.86 1.28
MACD -1.68 0.05
Stochastic Oscillator 36.37 52.55

Price Performance

Historical Comparison
ALNT
ZYME

About ALNT Allient Inc.

Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty controlled motion components and systems. The firm mainly caters to the Industrial, Vehicle, Aerospace & Defense, and Medical sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: